How Has Japan’s Cannabis Control Act Been Amended?
The 2023 amendment represents a significant shift in Japan's cannabis policy, aiming to balance expanded medical and industrial opportunities with continued drug control. Its practical implications remain to be seen and warrant close monitoring in the coming years.
Authors
- Kozo Akino
- Chikako Yoshida (ORCID: https://orcid.org/0000-0001-9147-4743)
- Ayako Mikami (ORCID: https://orcid.org/0000-0001-8124-8216)
- Munenori Katayama (ORCID: https://orcid.org/0000-0001-5614-0000)
- Nobuhiro Miki
- Ichiro Takumi (ORCID: https://orcid.org/0000-0001-5045-8077)
- Yuji Masataka (ORCID: https://orcid.org/0000-0003-1831-1512)
- Yoshiyuki Akahoshi
- Ryuto Nakazawa
- Toshihiko Matsumoto (ORCID: https://orcid.org/0000-0002-8195-605X)
- KATSUHEI SHIBATA
- Futaba Umemura
Institutions
- Nihon University (JP)
- Capital One (United States) (US)
- St. Marianna University School of Medicine (JP)
- National Center of Neurology and Psychiatry (JP)
- Astronomical Society of Japan (JP)
- National Center For Child Health and Development (JP)
- Shibuya (Japan) (JP)
- Fukuoka Prefecture Education Center (JP)
- Kanagawa Prefecture Medical Association (JP)
- Niigata University (JP)
Publication Details
- Journal
- Cannabis and Cannabinoid Research
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1089/can.2025.0006
- Citations
- 3
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 4.18